Clinical trial
Pleconaril Enteroviral Sepsis Syndrome
NCT00031512 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00031512 |
|---|---|
| Title | Pleconaril Enteroviral Sepsis Syndrome |
| Official title | A Double-Blind, Placebo-Controlled, Virologic Efficacy Trial of Pleconaril in the Treatment of Neonates With Enteroviral Sepsis Syndrome |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Enterovirus Infection |
| Intervention type | Drug, Other |
| Interventions | Placebo, Pleconaril |
| Enrollment | 61 |
| Start date | Jun 27, 2001 |
| Primary completion | Sep 22, 2010 |
| Completion | Sep 15, 2012 |
| First posted | Mar 7, 2002 |
| Last update posted | Feb 5, 2024 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: